Medical Advocates
Pneumocystis jirovecii (carinii) Pneumonia
  Prevention

 HIV-associated  jirovecii (carinii) Pneumonia 
HIV-negative Pneumocystis jirovecii (carinii) Pneumonia 








 
P. Pneumonia Main Page Main New/Noteworthy Home Page     
Last Update:  June 26, 2008
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
HIV-associated jirovecii (carinii) Pneumonia 
       

          Internet Documents

  FULL-TEXT GUIDELINES
2001 USPHS/IDSA Guidelines for the Prevention of Opportunistic Infections in Persons
Infected with HIV
Guidelines

           Journal Papers, Abstracts, and Commentaries

 
FULL TEXT PDF ARTICLE
Preventive effect of sulfamethoxasole-trimethoprim on Pneumocystis jiroveci pneumonia in
patients with interstitial pneumonia.
Enomoto T, Azuma A, Matsumoto A
Intern Med. 2008;47(1):15-20.
 Paper
 
Prophylaxis against Pneumocystis pneumonia in patients with inflammatory bowel disease:
Toward a standard of care.
Poppers DM, Scherl EJ.
Inflamm Bowel Dis. 2007 Sep 20;
 Abstract
 
High Rates of Primary Mycobacterium avium Complex and Pneumocystis jiroveci Prophylaxis
in the United States.
Gebo KA, Fleishman JA, Reilly ED, et al
Med Care. 2005 Sep;43(9 suppl):23-30.
 Abstract

Aerosolized pentamidine prophylaxis against AIDS-related Pneumocystis carinii pneumonia
and its short- and long-term effects on pulmonary function in the Japanese.
Konishi M, Yoshimoto E, Takahashi K, et al
J Infect Chemother. 2003 Jun;9(2):178-182.
Abstract

Pneumocystis carinii pneumonia prophylaxis in HIV negative patients with primary CNS
lymphoma.
Mathew BS, Grossman SA.
Cancer Treat Rev 2003 Apr;29(2):105-119
 Abstract
 
Successful prophylaxis against Pneumocystis carinii pneumonia in HIV-infected
children using smaller than recommended dosages of trimethoprim-sulfamethoxazole.
Fisher RG, Nageswaran S, Valentine ME, McKinney RE Jr.  
AIDS Patient Care STDS 2001 May;15(5):263-9
 Abstract
 
Underuse of Primary Mycobacterium avium Complex and Pneumocystis carinii
Prophylaxis in the United States.
 Asch SM, Gifford AL, Bozzette SA, et al.
J Acquir Immune Defic Syndr 2001 Dec 1;28(4):340-344
 Abstract
 
Discontinuation of Pneumocystis carinii Prophylaxis in Patients Infected with Human
Immunodeficiency Virus: A Meta-Analysis and Decision Analysis.
Trikalinos TA, Ioannidis JP.
 Clin Infect Dis 2001 Dec 1;33(11):1901-9
Abstract
 
HIV-negative Pneumocystis jirovecii (carinii) Pneumonia 
       

           Journal Papers, Abstracts, and Commentaries
 
 
Prophylaxis of Pneumocystis Pneumonia in Immunocompromised Non-HIV-Infected
Patients: Systematic Review and Meta-analysis of Randomized Controlled Trials.
Green H, Paul M, Vidal L, Leibovici L.
Mayo Clin Proc. 2007 Sep;82(9):1052-9.
 Abstract
 
Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients.
Green H, Paul M, Vidal L, Leibovici L. 
Cochrane Database Syst Rev. 2007 Jul 18;(3):CD005590.
 Abstract

Prevention of Infection Due to Pneumocystis spp. in Human Immunodeficiency Virus-
Negative Immunocompromised Patients.
Rodriguez M, Fishman JA.
Clin Microbiol Rev. 2004 Oct;17(4):770-82.
 Abstract

P. Pneumonia Main Page Main New/Noteworthy Home Page     

Pneumocystis jirovecii (carinii) Pneumonia
 Prevention